These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19117254)

  • 1. Etonogestrel implant in women with diabetes mellitus.
    Vicente L; Mendonça D; Dingle M; Duarte R; Boavida JM
    Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):387-95. PubMed ID: 19117254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels.
    Dilbaz B; Ozdegirmenci O; Caliskan E; Dilbaz S; Haberal A
    Contraception; 2010 Jun; 81(6):510-4. PubMed ID: 20472118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period.
    Villas-Boas J; Vilodre LC; Malerba H; Pontremoli Salcedo M; Foresti Jiménez M; El Beitune P
    Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():51-4. PubMed ID: 27164485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of contraceptive implants in adolescents.
    Guazzelli CA; de Queiroz FT; Barbieri M; Barreiros FA; Torloni MR; Araujo FF
    Contraception; 2011 Oct; 84(4):409-12. PubMed ID: 21920197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on carbohydrate metabolism and analysis of acceptability (menstrual cycle control) of extended regimens of the vaginally inserted hormone-releasing system 'NuvaRing' as compared with the standard 21/7 regime in reproductive-age women with type 1 diabetes mellitus.
    Grodnitskaya EE; Grigoryan OR; Klinyshkova EV; Andreeva EN; Melnichenko GA; Dedov II
    Gynecol Endocrinol; 2010 Sep; 26(9):663-8. PubMed ID: 20334583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
    Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
    Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population.
    Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C
    Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: a comparative study.
    Oderich CL; Wender MC; Lubianca JN; Santos LM; de Mello GC
    Contraception; 2012 Feb; 85(2):173-6. PubMed ID: 22067787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
    Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
    Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
    Hernandez-Juarez J; Garcia-Latorre EA; Moreno-Hernandez M; Moran-Perez JF; Rodriguez-Escobedo MA; Cogque-Hernandez G; Julián-Nacer R; Hernandez-Giron X; Palafox-Gomez R; Isordia-Salas I; Majluf-Cruz A
    Reprod Health; 2014 Apr; 11():33. PubMed ID: 24767248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Davis A; Swartz M; Guiahi M
    Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L; Brache V; Ali M; Habib N;
    Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of nomegestrol acetate subdermal implant (Uniplant) on carbohydrate metabolism, serum lipoproteins and on hepatic function in women.
    Barbosa I; Coutinho E; Athayde C; Ladipo O; Olsson SE; Ulmsten U
    Contraception; 1995 Aug; 52(2):111-4. PubMed ID: 8536447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.